Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 6 | $397,510,553 |
| Sells | 36 | $36,634,711 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 03 Jul 2024 16:05 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | Director | 01 Jul 2024 | Sale | 25,000 | 41.1814 | 1,029,535 | D |
| 05 Jun 2024 16:05 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | Director | 03 Jun 2024 | Sale | 50,000 | 40.6104 | 2,030,520 | D |
| 14 May 2024 17:16 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | Director | 10 May 2024 | Sale | 50,000 | 42.1025 | 2,105,125 | D |
| 03 Apr 2024 16:15 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | Director | 01 Apr 2024 | Sale | 50,000 | 42.3328 | 2,116,640 | D |
| 06 Mar 2024 16:15 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | Director | 04 Mar 2024 | Sale | 50,000 | 41.011 | 2,050,550 | D |
| 04 Mar 2024 17:49 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | Director | 29 Feb 2024 | Sale | 50,000 | 41.1578 | 2,057,890 | D |
| 08 Feb 2024 19:19 | CERE | Cerevel Therapeutics Holdings Inc | RENGER JOHN | Chief Scientific Officer | 07 Feb 2024 | Sale | 2,161 | 41.5441 | 89,777 | D |
| 08 Feb 2024 19:14 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | Director | 07 Feb 2024 | Sale | 2,506 | 41.5441 | 104,110 | D |
| 04 Jan 2024 16:15 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | Director | 02 Jan 2024 | Sale | 50,000 | 42.2363 | 2,111,815 | D |
| 28 Dec 2023 16:15 | CERE | Cerevel Therapeutics Holdings Inc | SANCHEZ RAMIRO | Chief Medical Officer | 26 Dec 2023 | Sale | 10,000 | 42.47 | 424,700 | D |
| 27 Dec 2023 16:15 | CERE | Cerevel Therapeutics Holdings Inc | DIPIETRO KENNETH | Chief Human Resources Officer | 22 Dec 2023 | Sale | 8,000 | 41.451 | 331,608 | D |
| 21 Dec 2023 20:27 | CERE | Cerevel Therapeutics Holdings Inc | BODENRADER MARK | See Remarks | 20 Dec 2023 | Sale | 7,889 | 41.4232 | 326,788 | D |
| 21 Dec 2023 20:24 | CERE | Cerevel Therapeutics Holdings Inc | DIPIETRO KENNETH | Chief Human Resources Officer | 20 Dec 2023 | Sale | 6,256 | 41.4232 | 259,144 | D |
| 21 Dec 2023 20:21 | CERE | Cerevel Therapeutics Holdings Inc | AKAMINE SCOTT | Chief Legal Officer | 20 Dec 2023 | Sale | 7,072 | 41.4232 | 292,945 | D |
| 21 Dec 2023 20:14 | CERE | Cerevel Therapeutics Holdings Inc | SANCHEZ RAMIRO | Chief Medical Officer | 20 Dec 2023 | Sale | 10,152 | 41.4232 | 420,528 | D |
| 21 Dec 2023 20:12 | CERE | Cerevel Therapeutics Holdings Inc | ALTSCHULLER SUSAN | Chief Financial Officer | 20 Dec 2023 | Sale | 13,808 | 41.4232 | 571,972 | D |
| 21 Dec 2023 20:10 | CERE | Cerevel Therapeutics Holdings Inc | TREGONING KATHLEEN | See Remarks | 20 Dec 2023 | Sale | 6,288 | 41.4232 | 260,469 | D |
| 19 Dec 2023 16:15 | CERE | Cerevel Therapeutics Holdings Inc | SANCHEZ RAMIRO | Chief Medical Officer | 15 Dec 2023 | Sale | 7,500 | 41.3857 | 310,393 | D |
| 11 Dec 2023 16:17 | CERE | Cerevel Therapeutics Holdings Inc | SANCHEZ RAMIRO | Chief Medical Officer | 07 Dec 2023 | Sale | 10,000 | 41.37 | 413,700 | D |
| 07 Dec 2023 19:45 | CERE | Cerevel Therapeutics Holdings Inc | AKAMINE SCOTT | Chief Legal Officer | 07 Dec 2023 | Sale | 10,000 | 41.37 | 413,700 | D |
| 07 Dec 2023 19:45 | CERE | Cerevel Therapeutics Holdings Inc | AKAMINE SCOTT | Chief Legal Officer | 05 Dec 2023 | Sale | 7,500 | 35 | 262,500 | D |
| 16 Nov 2023 16:15 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | Director | 14 Nov 2023 | Sale | 22,824 | 25.1251 | 573,455 | D |
| 09 Nov 2023 17:03 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | Director | 08 Nov 2023 | Sale | 100 | 25.16 | 2,516 | D |
| 09 Nov 2023 17:03 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | Director | 07 Nov 2023 | Sale | 27,076 | 25.0242 | 677,555 | D |
| 06 Nov 2023 17:12 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | Director | 03 Nov 2023 | Sale | 61,401 | 25.4305 | 1,561,458 | D |
| 06 Nov 2023 17:12 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | Director | 02 Nov 2023 | Sale | 38,599 | 25.1882 | 972,239 | D |
| 03 Nov 2023 16:15 | CERE | Cerevel Therapeutics Holdings Inc | PATRICK DEVAL L | Director | 01 Nov 2023 | Sale | 30,130 | 25 | 753,250 | D |
| 18 Oct 2023 16:30 | CERE | Cerevel Therapeutics Holdings Inc | GORDON CHRISTOPHER R | Director , 10% | 16 Oct 2023 | Purchase | 5,480,052 | 22.81 | 124,999,986 | I |
| 18 Oct 2023 16:30 | CERE | Cerevel Therapeutics Holdings Inc | KOPPEL ADAM | Director , 10% | 16 Oct 2023 | Purchase | 5,480,052 | 22.81 | 124,999,986 | I |
| 18 Oct 2023 16:30 | CERE | Cerevel Therapeutics Holdings Inc | BAIN CAPITAL INVESTORS LLC | 10% | 16 Oct 2023 | Purchase | 5,480,052 | 22.81 | 124,999,986 | I |
| 17 Oct 2023 16:53 | CERE | Cerevel Therapeutics Holdings Inc | PERCEPTIVE ADVISORS LLC | Director | 16 Oct 2023 | Purchase | 876,808 | 22.81 | 19,999,990 | I |
| 08 Sep 2023 16:35 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | Director | 07 Sep 2023 | Sale | 50,000 | 24.0683 | 1,203,415 | D |
| 07 Aug 2023 17:13 | CERE | Cerevel Therapeutics Holdings Inc | RENAUD RONALD C JR | President & CEO | 03 Aug 2023 | Purchase | 83,857 | 23.9552 | 2,008,811 | I |
| 07 Aug 2023 17:11 | CERE | Cerevel Therapeutics Holdings Inc | BURGESS PAUL D. | See Remarks | 04 Aug 2023 | Purchase | 21,880 | 22.9339 | 501,794 | D |
| 13 Jul 2023 17:41 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | Director | 11 Jul 2023 | Sale | 50,000 | 30.0268 | 1,501,340 | D |
| 20 Jun 2023 16:56 | CERE | Cerevel Therapeutics Holdings Inc | DEKKERS MARIJN E | Director | 15 Jun 2023 | Sale | 200,000 | 34.43 | 6,886,000 | I |
| 05 Jun 2023 20:12 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | CEO and Chairperson | 01 Jun 2023 | Sale | 50,000 | 32.6014 | 1,630,070 | D |
| 05 Jun 2023 20:07 | CERE | Cerevel Therapeutics Holdings Inc | BODENRADER MARK | See Remarks | 02 Jun 2023 | Sale | 1,895 | 32.95 | 62,440 | D |
| 08 May 2023 16:24 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | CEO and Chairperson | 04 May 2023 | Sale | 300 | 32.93 | 9,879 | D |
| 08 May 2023 16:24 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | CEO and Chairperson | 04 May 2023 | Sale | 12,132 | 31.7579 | 385,287 | D |
| 08 May 2023 16:24 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | CEO and Chairperson | 04 May 2023 | Sale | 37,568 | 31.3636 | 1,178,268 | D |
| 13 Apr 2023 16:48 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | CEO and Chairperson | 11 Apr 2023 | Sale | 50,000 | 25.0626 | 1,253,130 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)